Phase 2 Acute Myeloid Leukemia, Relapsed Clinical Trials

3 recruitingPhase 2

What is a Phase 2 trial?

Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.

Showing 1–3 of 3 trials

Recruiting

Phase 2Phase 3

Co-infusion of Treg-enriched Donor Lymphocytes With CD3-depleted Hematopoietic Stem Cell Graft to Prevent Graft-versus Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation Among Children With Hematologic Malignancies

Acute Myeloid Leukemia, RelapsedAcute Lymphoblastic Leukemia, High RiskAcute Myeloid Leukemia, High Risk+1 more

Federal Research Institute of Pediatric Hematology, Oncology and Immunology64 enrolled1 locationNCT07366801

Recruiting

Phase 2

Intensity Modulated Total Marrow Irradiation in Fully Human Leukocyte Antigen (HLA)-Matched and Partially-HLA Mismatched Allogeneic Transplantation Patients With High-Risk Acute Myeloid Leukemia (AML), Chronic Myeloid Leukemia (CML), and Myelodysplastic Syndrome (MDS)

Acute Myeloid Leukemia, Relapsed, Adult

University of Illinois at Chicago38 enrolled1 locationNCT06802315

Recruiting

Phase 2

CLAG-GO for Patients With Persistent, Relapsed or Refractory AML

Acute Myeloid Leukemia, AdultAcute Myeloid Leukemia RecurrentAcute Myeloid Leukemia, Relapsed, Adult

University of Maryland, Baltimore39 enrolled1 locationNCT04050280